Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep46 | Adrenal and Cardiovascular Endocrinology | ECE2021

High-normal serum uric acid levels in Type 2 diabetes patients with atherosclerotic cardiovascular diseases

Khalaf Rahma , Ali Zohra Hadj , Htira Yosra , Mami Faika Ben

Background and aimHyperuricemia is linked to a variety of diseases such as atherosclerotic cardiovascular disease (ASCVD). There are controversial data concerning the significance of high-normal values of serum uric acid (SUA) in patients with T2DM and cardiovascular disease. The aim of the study is to assess SUA levels in Type 2 diabetes mellitus (T2DM) patients with ASCVD.Patients and methodsThis retrospect...

ea0073aep242 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Post hip-fracture rehabilitation outcomes of diabetic and non-diabetic elderly patients

Ben-Joseph Ronen , luboshitz Barak , Heffez-Ayzenfeld Rachel , Twito Orit

BackgroundAlthough patients with diabetes mellitus (DM) are at higher risk of hip fracture, data regarding the effect of DM on rehabilitation outcomes is limited.MethodsA retrospective population-based study was conducted comparing diabetic and non-diabetic elderly patients with a recent hip fracture who were admitted to a geriatric rehabilitation facility during 2014–2019. The Functional Independence Me...

ea0073aep277 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Frequency of obesity among individuals with spondylarthritis

Khaoula Ben Ali , Slouma Maroua , Zouaoui Chadia , Gharsallah Imen

BackgroundSpondylarthritis may be associated with substantial burden of comorbidities, which can increase the cardiovascular risk. Obesity if associated with spondylarthritis not only can rise the risk of a possible heart disease but it may also deteriorate their functional prognosis.ObjectivesThe main target of this study was to evaluate the frequency of obesity in spondylarthritis patients.<p class="abs...

ea0073aep278 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Response to direct antiviral agents in chronic hepatitis C in patients with metabolic syndrome

Soumaya Mrabet , raida harbi , Akkari Imen , Elhem Ben Jazia

IntroductionDirect antiviral agents (DAAs) are a real revolution in the treatment of chronic hepatitis c (CHC). It is a short-term treatment with few side effects. Insulin resistance in patients with metabolic syndrome, causes the onset of steatosis, contributes to the progression to cirrhosis and decreases the chances of a response to treatment. The aim of our study was to evaluate the response to DAAs in patients with metablic syndrome.<p class="ab...

ea0073aep283 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Diabetic nephropathy in absence of diabetic retinopathy in type 2 diabetes mellitus patients

Khalaf Rahma , Ali Zohra Hadj , Htira Yosra , Mami Faika Ben

BackgroundThere is a well-recognized association between diabetic retinopathy (DN) and diabetic nephropathy (DN), in which nephropathy without retinopathy is rare but retinopathy without nephropathy is common.AimTo highlight the discordance between retinopathy and nephropathy and describe a series of patients with diabetic nephropathy who had no evidence of diabetic retinopathy.Methods<...

ea0073aep321 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Immune thrombocytopenia presenting with celiac disease and Hashimoto’s Thyroiditis in type 2 diabetes patient: A case report

Khalaf Rahma , Ali Zohra Hadj , Htira Yosra , Mami Faika Ben

IntroductionThe combination of at least three autoimmune diseases in the same patient is defined as multiple autoimmune syndrome. Recent studies demonstrated a higher prevalence of celiac disease in patients with immune thrombocytopenia when compared to the general population. Here we report the occurrence of celiac disease, Hashimoto’s disease and immune thrombocytopenia in type 2 diabetes patient.Case report<p class="abs...

ea0073aep328 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Non alcoholic steatohepatitis related cirrhosis and hepatocellulair carcinoma: A ten years rerospective study

Soumaya Mrabet , Raida Harbi , Akkari Imen , Elhem Ben Jazia

IntroductionCurrently, the incidence of metabolic steatopathies is clearly increasing. Unlike simple fatty liver disease, non-alcoholic steatohepatitis (NASH) can progress to cirrhosis and hepatocellular carcinoma (HCC). The aim of our study was to determine the factors associated with these complications in patients with NASH.MethodsThis is a retrospective study including all cirrhotic patients followed betw...

ea0073aep358 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Impact of diabetes on liver fibrosis in chronic hepatitis C

Soumaya Mrabet , Raida Harbi , Akkari Imen , Elhem Ben Jazia

IntroductionChronic hepatitis C (CHC) is associated with an increased incidence of insulin resistance and diabetes mellitus. Obesity and insulin resistance are associated with faster progression of fibrosis in these patients. The aim of our study was to assess the impact of diabetes on the severity of hepatic fibrosis in patients followed for CHC.MethodsThis is a retrospective study conducted between January ...

ea0073aep714 | Thyroid | ECE2021

Thyroid disease in insulin- treated type 2 diabetes mellitus

Khalaf Rahma , Hadj Ali Zohra , Htira Yosra , Ben Mami Faika

Background and aimAbundant evidence suggests an association between thyroid disease and type 2 diabetes mellitus (T2DM). To determine the interaction between these co-existing pathologies, we analyzed insulin-treated type 2 diabetes patients with diagnosed thyroid disease.Patients and methodsThis retrospective study was performed in 54 type 2 diabetes patients who had been admitted for insulin-treatment and d...

ea0073ep65 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Glycemic control and microvascular complications in patients with type 1 diabetes and treated celiac disease

Khalaf Rahma , Hadj Ali Zohra , Htira Yosra , Ben Mami Faika

BackgroundCeliac disease (CD) occurs in patients with type1 diabetes (T1DM) ranging the prevalence of 4.4–11.1% versus 0.5% of the general population. The mechanism of association of these two diseases involves a shared genetic background.AimTo investigate whether in type1 diabetes (T1DM) patients the concomitance of treated celiac disease (CD) impacts glycemic control and the prevalence of microvascular...